DW Healthcare Partners (“DWHP”) a healthcare-focused private equity firm, announced the completion of its investment in Parnell Pharmaceuticals Holdings Ltd (OTC: PARNF) (“Parnell” or the “Company”). Founded over 50 years ago in Australia, Parnell is a fully integrated manufacturer and developer of animal health pharmaceuticals focused on the US market. “Parnell has an attractive position with an FDA approved manufacturing facility dedicated to animal health drugs with a particular focus on sterile injectables,” said Eric Moore, Principal at DWHP.
Read the full article: DW Healthcare Partners Invests in Parnell //
Source: https://www.prnewswire.com/news-releases/dw-healthcare-partners-invests-in-parnell-301219519.html